The most common conditions

Title Effect Research Type Journal Year
Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers. positive humans Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2013
The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids. positive animals Pharmacology, biochemistry, and behavior 2013
A pilot study of orally administered Δ(1)-trans-tetrahydrocannabinol in the management of patients undergoing radiotherapy for carcinoma of the bronchus. positive humans British journal of clinical pharmacology 1974
Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey. positive humans Anesthesiology research and practice 2009
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. NONE humans Journal of pain and symptom management 2010
Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation. NONE humans Molecular vision 2008
Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception. positive animals European journal of pharmacology 2008
Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy. positive humans The journal of pain : official journal of the American Pain Society 2008
Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : a double-blind placebo-controlled cross-over trial. positive humans Journal of neurology 2006
Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief. positive humans Current medical research and opinion 2006
Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study. NONE humans Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2017
A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis. positive humans Journal of pain research 2016
Sex-dependent effects of cannabis-induced analgesia. positive humans Drug and alcohol dependence 2016
[Delta(9)-tetrahydrocannabinol and the opioid receptor agonist piritramide do not act synergistically in postoperative pain]. NONE humans Der Anaesthesist 2006
Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine. NONE humans European journal of pharmacology 2006
An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease. positive humans The journal of pain : official journal of the American Pain Society 2016
Development and pharmacokinetic characterization of pulmonal and intravenous delta-9-tetrahydrocannabinol (THC) in humans. NONE humans Journal of pharmaceutical sciences 2004
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. NONE humans Lancet (London, England) 2003
Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain. NONE humans Pain 2003
The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions. positive humans Pain 2003
[The therapeutic use of D9-tetrahydrocannabinol (dronabinol) in refractory neuropathic pain]. NONE humans Presse medicale (Paris, France : 1983) 2002
Pharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and [INCREMENT]9-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats. NONE animals Behavioural pharmacology 2016
[Tetrahydrocannabinol for treatment of chronic pain]. NONE humans Schmerz (Berlin, Germany) 2001
Brain Mapping-Based Model of Δ(9)-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix. positive humans Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2016
Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy. positive humans The journal of pain : official journal of the American Pain Society 2015
Tonic analgesic effects of delta 9-tetrahydrocannabinol as measured with the formalin test. positive animals European journal of pharmacology 1980
Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial. positive humans European archives of psychiatry and clinical neuroscience 1990
Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain. positive animals European journal of pharmacology 2014
Analgesic effect of delta-9-tetrahydrocannabinol. positive humans Journal of clinical pharmacology 1975
Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response. NONE humans Clinical pharmacology and therapeutics 1977
The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study. positive humans Journal of pain & palliative care pharmacotherapy 2014
The analgesic properties of delta-9-tetrahydrocannabinol and codeine. positive humans Clinical pharmacology and therapeutics 1975
Title Effect Research Type Journal Year
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis. positive humans Journal of neurology 2013
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. positive humans Journal of pain and symptom management 2010
Single and combined effects of Δ9 -tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain. positive animals British journal of pharmacology 2017
Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial. positive humans Pain 2007
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. positive humans Neurology 2005
Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial. positive humans Pain 2004
Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial. NONE humans Pain 2004
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment. positive humans European journal of pain (London, England) 2014